Clinical Trial Update: Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Ropeginterferon in patients with cutaneous T-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma

Drugs mentioned

• Ropeginterferon (ropeginterferon alfa-2b)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Cutaneous T Cell Lymphoma | Phase 1 | Status: RECRUITING